Peking University Shenzhen Hospital

Cardiovascular Surgery

The Department of Cardiovascular Surgery at Peking University Shenzhen Hospital was formally established when the hospital opened in 1999. After more than 20 years of work, it has developed into a comprehensive discipline integrating medical care, education and research. It is a standing-committee unit of the Cardiovascular Surgery Physicians Branch of the Chinese Medical Doctor Association; the deputy-chair unit of the Cardiovascular Surgery Professional Committee of the Guangdong Medical Association and a standing-committee unit of the Cardiovascular Surgery Physicians Branch of the Guangdong Medical Doctor Association; and the chair unit of the Cardiovascular Surgery Branch of the Shenzhen Medical Association and the president unit of the Cardiovascular Surgery Branch of the Shenzhen Medical Doctor Association. As a key hospital discipline and a Category B discipline in the high-level hospital development program of Guangdong Province, it currently has 12 clinical physicians, including seven with senior professional titles and four with intermediate titles, and 49 nursing staff. The department has 37 beds in general wards, including six intensive care beds. For five consecutive years, the discipline has ranked among the national top 100 cardiovascular surgery specialties in the China Hospital Science and Technology Value (STEM) ranking; in 2022 it ranked 51st nationally and 5th in Guangdong, remained first in Shenzhen for three consecutive years, and ranked 64th nationally in cardiovascular surgery by five-year total science and technology value (ASTEM). It routinely performs surgical treatment for various heart, great-vessel and peripheral vascular diseases, and specializes in minimally invasive and percutaneous interventional treatment of thoracoabdominal aortic dissection, thoracoabdominal aortic aneurysm, valvular heart disease, congenital heart disease and peripheral arterial disease. In recent years it performed Shenzhen’s first integrated-stent endovascular aortic repair, first transapical minimally invasive aortic valve replacement (TAVR), first percutaneous left atrial appendage occlusion, first dry-type ventricular septal defect procedure in the Shenzhen area, and first percutaneous interventional mitral valve clip repair (MITRACLIP) in Shenzhen, among others. It routinely uses cardiac assist technologies such as ECMO and IABP to treat severe heart failure, perioperative cardiac insufficiency and severe cardiomyopathy. It is a treatment center for critical cardiac diseases in Shenzhen; annual surgical volume exceeds 600 procedures and has long ranked first among Shenzhen general hospitals. It achieved survival of an infant after deep hypothermic circulatory arrest in the fourth national case of pregnancy complicated by aortic dissection. It set the national record for successful surgery in the patient with the greatest body weight and type A aortic dissection (body weight 161 kg). It enjoys a high reputation in South China and was nominated for cardiovascular surgery in the South China China Hospital Reputation Ranking for two consecutive years; in 2018 it ranked first in cardiovascular surgery in the Shenzhen Medical and Health Institutions Science and Technology Influence Ranking. In the past five years, the department has received four National Natural Science Foundation grants, one National Key R&D Program project (as a collaborating project), two China Postdoctoral Science Foundation grants, one Guangdong Natural Science Foundation grant, seven Shenzhen Science and Technology Innovation Commission research grants, two Shenzhen Academy of Medical Sciences projects, and more than 20 national patents. It has published nearly 200 academic papers, including more than 30 indexed in SCI; in 2021 it published one paper in the top specialty journal Circulation (impact factor 29.69). The discipline is one of the first cardiovascular surgery specialist physician standardized training bases certified by Peking University Health Science Center, a Guangdong training base for cardiovascular disease nursing and technical standards, and a Shenzhen standardized residency training base for cardiothoracic surgery. Many department members supervise master’s students at Peking University Health Science Center, Southern University of Science and Technology, Anhui Medical University, Shenzhen University, Guangdong Medical University, Shantou University Medical College, Weifang Medical University, Hubei Pharmaceutical University and Zunyi Medical University, and provide high-quality supervision for graduate students, standardized trainees and interns. Guided by the goal of patient safety and oriented toward patient needs, the discipline adheres to the treatment principles of minimally invasive and comprehensive care, remains committed to serving patients with the most advanced technologies, keeps abreast of advanced domestic and international techniques, and strives to provide the best medical services for patients.